Neurotherapeutic Effects of Quercetin and Its Metabolite Compounds on Cognitive Impairment and Parkinson's Disease: An In Silico Study.

Published in: European journal of drug metabolism and pharmacokinetics (2023)

This study identified 28 quercetin metabolite products. The metabolites have similar characteristics to quercetin such as physicochemical properties, absorption, distribution, metabolism, and excretion (ADME), and biological activities. More research, especially clinical trials, is needed to find out how quercetin and its metabolites protect against CI and PD.

Keyphrases

clinical trial
cognitive impairment
molecular docking
study protocol
molecular dynamics simulations
phase iii